Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection
Vox Sanguinis · 2026-08 · 121 (8) · 1103-1109
DOI: 10.1111/vox.70245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vox Sanguinis, online erschienen am 17.03.2026. Verfasst von Jean-Baptiste Thibert und 7 weiteren Autor:innen. Beteiligte Einrichtung: EFS Bretagne, Rennes, France. Hauptthemen laut MEDLINE: Human Rights, Blood Donors, Plasma, Health Services Accessibility. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Objectives The main use of plasma has evolved into market‐driven plasma‐derived medicinal products (PDMPs), but it still requires donors. Availability of PDMPs in access to care is often considered restrictively, in terms of volumes of plasma required for production and whether or not to remunerate donors. Unfortunately, this leads to an inability to meet today's challenges, both in terms of patient access to treatment and donor protection. Materials and Methods Here we review how the current challenges can be held under two major human fundamental rights and their associated ethical principles: the right to health protection and the right to human dignity.
Results
Our research shows how advantageous it could be to reposition the fundamental right to health protection as an input parameter for decisions on the transfusion and plasma supply chain, as this would enable reconciliation of both patient access to these therapies and the protection of donors. This objective means that actions must be prioritized on parameters that do not impact human rights so that the plasma donated is fully exploited and the donors adequately protected.
Conclusion
Decisions could be made within the remit of human rights, and finally go over the opposition between access to care and donor health protection. As PDMPs have created a kind of international human interdependence, it is our responsibility to place both patients and donors under the umbrella of fundamental human rights, to act not as if a choice has to be made between the two, but in ways that protect them both.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- EFS Bretagne, Rennes, France.
- Institute of Law and Politic Science, UR4640, University of Rennes, Rennes, France.
- International Plasma and Fractionation Association, Amsterdam, the Netherlands.
- Association Française contre les Neuropathies Périphériques (AFNP), La Baule, France.
- Centro Nazionale Sangue, Rome, Italy.
- Department of Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
ORCID-Profile: Jean-Baptiste Thibert, Leni von Bonsdorff, Cynthia So-Osman, Pierre Tiberghien
Zitieren
APA
Thibert, J. B., von Bonsdorff, L., Plançon, J. P., de Angelis, V., So-Osman, C., Erikstrup, C., Tiberghien, P., & van den Hurk, K. (2026). Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection. Vox Sanguinis, 121(8), 1103-1109. https://doi.org/10.1111/vox.70245
Vancouver
Thibert JB, von Bonsdorff L, Plançon JP, de Angelis V, So-Osman C, Erikstrup C, et al. Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection. Vox Sanguinis. 2026;121(8):1103-1109. doi:10.1111/vox.70245
BibTeX
@article{Thibert2026,
author = {Thibert, Jean-Baptiste and von Bonsdorff, Leni and Plançon, Jean-Philippe and de Angelis, Vincenzo and So-Osman, Cynthia and Erikstrup, Christian and Tiberghien, Pierre and van den Hurk, Katja},
title = {Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection},
journal = {Vox Sanguinis},
year = {2026},
volume = {121},
number = {8},
pages = {1103--1109},
doi = {10.1111/vox.70245}
}
EUVIMED